TD Cowen Maintains Sell on RXO, Lowers Price Target to $17.5

Benzinga Newsdesk www.benzinga.com Negative 81.5%

Neg 81.5% Neu 0% Pos 0%

TD Cowen analyst Jason Seidl maintains RXO (NYSE:RXO) with a Sell and lowers the price target from $19 to $17.5.

Comments

No comments yet. Be the first!